Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice
暂无分享,去创建一个
Yu Tian | Xiaohui Fan | Xiaoyan Lu | Xiaohui Fan | X. Lu | Qinqin Zhao | Tingting Jin | Yu Tian | S. Xiao | Shun Xiao | Qinqin Zhao | Tingting Jin | Xiaoyan Lu
[1] T. Xia,et al. Toxic Potential of Materials at the Nanolevel , 2006, Science.
[2] K. Audus,et al. Microparticulate uptake mechanisms of in‐vitro cell culture models of the respiratory epithelium , 2001, The Journal of pharmacy and pharmacology.
[3] David M. Brown,et al. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. , 2001, Toxicology and applied pharmacology.
[4] Mina Choi,et al. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. , 2009, Toxicology letters.
[5] K. Wittmaack. In Search of the Most Relevant Parameter for Quantifying Lung Inflammatory Response to Nanoparticle Exposure: Particle Number, Surface Area, or What? , 2006, Environmental health perspectives.
[6] Tao-Tao Liu,et al. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[7] Ian D Wilson,et al. Analytical strategies in metabonomics. , 2007, Journal of proteome research.
[8] W. MacNee,et al. Role of transcription factors in inflammatory lung diseases , 1998, Thorax.
[9] A. Tas,et al. Sensitivity of (1)H NMR analysis of rat urine in relation to toxicometabonomics. Part I: dose-dependent toxic effects of bromobenzene and paracetamol. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[10] Warren C W Chan,et al. Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.
[11] Qian Bu,et al. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration , 2010, Nanotechnology.
[12] Agnes G Oomen,et al. What do we (need to) know about the kinetic properties of nanoparticles in the body? , 2007, Regulatory toxicology and pharmacology : RTP.
[13] Weimin Song,et al. Pulmonary responses to fine particles: differences between the spontaneously hypertensive rats and wistar kyoto rats. , 2007, Toxicology letters.
[14] J R Griffiths,et al. Pattern recognition analysis of 1H NMR spectra from perchloric acid extracts of human brain tumor biopsies , 1998, Magnetic resonance in medicine.
[15] Kieran Clarke,et al. A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. , 2006, Physiological genomics.
[16] Petra Krystek,et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.
[17] R M Albrecht,et al. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. , 2001, Journal of pharmaceutical sciences.
[18] Alan Aderem,et al. Phagocytosis and the inflammatory response. , 2003, The Journal of infectious diseases.
[19] W. Chan,et al. Nanotoxicity: the growing need for in vivo study. , 2007, Current opinion in biotechnology.
[20] C. M. Galhardi,et al. Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[21] Minbo Lan,et al. Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.
[22] V. Colvin. The potential environmental impact of engineered nanomaterials , 2003, Nature Biotechnology.
[23] T. Xia,et al. Impairment of mitochondrial function by particulate matter (PM) and their toxic components: implications for PM-induced cardiovascular and lung disease. , 2007, Frontiers in bioscience : a journal and virtual library.
[24] Qingxiu Wang,et al. Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity. , 2008, Toxicology and applied pharmacology.
[25] E Holmes,et al. The mechanism of galactosamine toxicity revisited; a metabonomic study. , 2007, Journal of proteome research.
[26] J. Nakanishi,et al. Comparative pulmonary toxicity study of nano-TiO(2) particles of different sizes and agglomerations in rats: different short- and long-term post-instillation results. , 2009, Toxicology.
[27] P. Watkins. Biomarkers for drug-induced liver injury , 2010 .
[28] P. So,et al. Metabolic effects of citrate in liver during cold hypoxia studied by 1H NMR spectroscopy. , 1998, Cryobiology.
[29] J. Pounds,et al. Macrophage responses to silica nanoparticles are highly conserved across particle sizes. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[30] J. Fuscoe,et al. Effect of (+)-usnic acid on mitochondrial functions as measured by mitochondria-specific oligonucleotide microarray in liver of B6C3F1 mice. , 2009, Mitochondrion.
[31] J. Lindon,et al. Systems biology: Metabonomics , 2008, Nature.
[32] H. Karlsson,et al. Size-dependent toxicity of metal oxide particles--a comparison between nano- and micrometer size. , 2009, Toxicology letters.
[33] Stephen J. Bruce,et al. Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets. , 2005, The Analyst.
[34] W. MacNee,et al. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area , 2007, Occupational and Environmental Medicine.
[35] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[36] Pratim Biswas,et al. Does nanoparticle activity depend upon size and crystal phase? , 2008, Nanotoxicology.
[37] Sung Jun Kim,et al. Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. , 2007, Toxicology letters.
[38] Scott C. Brown,et al. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[39] Yasuo Tsutsumi,et al. Silica nanoparticles as hepatotoxicants. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.